Léim chuig an ábhar
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Teanga
Gach réimse
Teideal
Údar
Ábhar
Gairmuimhir
ISBN/ISSN
Clib
AIMSIGH
CASTA
Karyotype is an independent pr...
Luaigh é seo
Seol mar théacs é seo
Seol é seo mar r-phost
Priontáil
Easpórtáil taifead
Easpórtáil chuig RefWorks
Easpórtáil chuig EndNoteWeb
Easpórtáil chuig EndNote
Buan-nasc
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:
Moorman, A
,
Harrison, C
,
Buck, G
,
Richards, S
,
Secker-Walker, L
,
Martineau, M
,
Vance, G
,
Cherry, A
,
Higgins, R
,
Fielding, A
,
Foroni, L
,
Paietta, E
,
Tallman, MS
,
Wernik, P
,
Litzow, MR
,
Rowe, J
,
Goldstone, A
,
Dewald, G
Formáid:
Conference item
Foilsithe / Cruthaithe:
2007
Stoc
Cur síos
Míreanna comhchosúla
Amharc foirne
Cur síos
Achoimre:
Míreanna comhchosúla
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia
de réir: Moorman, A, et al.
Foilsithe / Cruthaithe: (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
de réir: Moorman, A, et al.
Foilsithe / Cruthaithe: (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.
de réir: Moorman, A, et al.
Foilsithe / Cruthaithe: (2005)
Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial
de réir: Fielding, A, et al.
Foilsithe / Cruthaithe: (2010)
Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial
de réir: Fielding, A, et al.
Foilsithe / Cruthaithe: (2010)